TY - JOUR
T1 - Substrate-based approaches in ventricular tachycardia ablation
AU - Hawson, Joshua
AU - Al-kaisey, Ahmed
AU - Anderson, Robert D.
AU - Watts, Troy
AU - Morton, Joseph
AU - Kumar, Saurabh
AU - Kistler, Peter
AU - Kalman, Jonathan
AU - Lee, Geoffrey
N1 - Funding Information:
Saurabh Kumar has received honoraria from Biosense Webster, Abbott Medical, Biotronik, and Sanofi Aventis. Jonathan Kalman is supported by a National Health and Medical Research Council of Australia practitioner fellowship, and has received research and fellowship support from Biosense Webster , Abbott and Medtronic . Geoffrey Lee has received consulting fees and speaker honoraria from Biosense Webster . Other authors have no discloses.
Funding Information:
Saurabh Kumar has received honoraria from Biosense Webster, Abbott Medical, Biotronik, and Sanofi Aventis. Jonathan Kalman is supported by a National Health and Medical Research Council of Australia practitioner fellowship, and has received research and fellowship support from Biosense Webster, Abbott and Medtronic. Geoffrey Lee has received consulting fees and speaker honoraria from Biosense Webster. Other authors have no discloses.
Publisher Copyright:
© 2022 Indian Heart Rhythm Society
PY - 2022/11
Y1 - 2022/11
N2 - Catheter ablation for ventricular tachycardia (VT) in patients with structural heart disease is now part of standard care. Mapping and ablation of the clinical VT is often limited when the VT is noninducible, nonsustained or not haemodynamically tolerated. Substrate-based ablation strategies have been developed in an aim to treat VT in this setting and, subsequently, have been shown to improve outcomes in VT ablation when compared to focused ablation of mapped VTs. Since the initial description of linear ablation lines targeting ventricular scar, many different approaches to substrate-based VT ablation have been developed. Strategies can broadly be divided into three categories: 1) targeting abnormal electrograms, 2) anatomical targeting of conduction channels between areas of myocardial scar, and 3) targeting areas of slow and/or decremental conduction, identified with “functional” substrate mapping techniques. This review summarises contemporary substrate-based ablation strategies, along with their strengths and weaknesses.
AB - Catheter ablation for ventricular tachycardia (VT) in patients with structural heart disease is now part of standard care. Mapping and ablation of the clinical VT is often limited when the VT is noninducible, nonsustained or not haemodynamically tolerated. Substrate-based ablation strategies have been developed in an aim to treat VT in this setting and, subsequently, have been shown to improve outcomes in VT ablation when compared to focused ablation of mapped VTs. Since the initial description of linear ablation lines targeting ventricular scar, many different approaches to substrate-based VT ablation have been developed. Strategies can broadly be divided into three categories: 1) targeting abnormal electrograms, 2) anatomical targeting of conduction channels between areas of myocardial scar, and 3) targeting areas of slow and/or decremental conduction, identified with “functional” substrate mapping techniques. This review summarises contemporary substrate-based ablation strategies, along with their strengths and weaknesses.
KW - Functional substrate mapping
KW - ILAM
KW - Ventricular arrhythmias
KW - Ventricular tachycardia
UR - https://www.scopus.com/pages/publications/85139316328
U2 - 10.1016/j.ipej.2022.08.002
DO - 10.1016/j.ipej.2022.08.002
M3 - Review Article
C2 - 36007824
AN - SCOPUS:85139316328
SN - 0972-6292
VL - 22
SP - 273
EP - 285
JO - Indian Pacing and Electrophysiology Journal
JF - Indian Pacing and Electrophysiology Journal
IS - 6
ER -